"Isoantibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies from an individual that react with ISOANTIGENS of another individual of the same species.
| Descriptor ID |
D007518
|
| MeSH Number(s) |
D12.776.124.486.485.114.664 D12.776.124.790.651.114.664 D12.776.377.715.548.114.664
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Isoantibodies".
Below are MeSH descriptors whose meaning is more specific than "Isoantibodies".
This graph shows the total number of publications written about "Isoantibodies" by people in this website by year, and whether "Isoantibodies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Isoantibodies" by people in Profiles.
-
A Retrospective Study on Human Leukocyte Antigen Types and Haplotypes in a South African Population. Arch Pathol Lab Med. 2021 04 01; 145(4):441-447.
-
HLA antibody repertoire in infants suggests selectivity in transplacental crossing. Am J Reprod Immunol. 2020 08; 84(2):e13264.
-
A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors. Blood. 2019 12 12; 134(24):2127-2138.
-
The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study. Haemophilia. 2019 Jan; 25(1):33-44.
-
Emicizumab Prophylaxis in Hemophilia A with Inhibitors. N Engl J Med. 2017 08 31; 377(9):809-818.
-
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A. N Engl J Med. 2016 May 26; 374(21):2054-64.
-
Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity. J Thromb Haemost. 2015 Nov; 13(11):1989-98.
-
Key issues in inhibitor management in patients with haemophilia. Blood Transfus. 2014 Jan; 12 Suppl 1:s319-29.
-
Haemophilia management: time to get personal? Haemophilia. 2011 Sep; 17(5):721-8.
-
Renal xenotransplantation of allosensitized patients: are baboon lymphocytes suitable crossmatch targets? Transplant Proc. 1994 Jun; 26(3):1079.